Sino-American Tianjin SmithKline & French Laboratories

Sino-American Tianjin SmithKline & French Laboratories (abbreviated as Sino-American SK&F) is a pharmaceutical joint venture in the People's Republic of China, headquartered in Tianjin. Its joint venture parties are Tianjin Zhongxin Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., and the American company SmithKline Beecham. Its brands include Contac (compound pseudoephedrine hydrochloride sustained-release capsules), Fenbid (ibuprofen), Bactroban (mupirocin), SK&F Zental (albendazole), and Polident.

Sino-American Tianjin SmithKline & French Laboratories (abbreviated as Sino-American SK&F) is a pharmaceutical joint venture in the People's Republic of China, established with the United Kingdom (originally the United States at the time of founding), headquartered in Tianjin. The joint venture parties are Tianjin Zhongxin Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., and the American company SmithKline Beecham.

• Sino-American Tianjin SmithKline & French Laboratories was established as a joint venture between Chinese parties (Tianjin Zhongxin Pharmaceutical Group and Tianjin Pharmaceutical Group) and the American company SmithKline Beecham.

• Contac (compound pseudoephedrine hydrochloride sustained-release capsules)

• Fenbid (ibuprofen)

• Bactroban (mupirocin)

• SK&F Zental (albendazole)

• Polident

• 2000

  Source 1Source 2

Read more

1. 1Sino-American Tianjin SmithKline & French Laboratorieswikidata.org
2. 2中美史克zh.wikipedia.org
3. 3PPA风波：康泰克被暂停销售，损失约6亿元gmw.cn
4. 4PPA风波：康泰克被暂停销售，损失约6亿元news.sina.com.cn